Das Geld flieht:
Das ist kein Gold-Boom, das ist ein Systembruch – und er hat gerade erst begonnen
Anzeige

Changes in Siegfried's senior management team 06.12.2024, 06:30 Uhr von EQS News Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
Siegfried Holding AG Namen-Akt 87,03 CHF -0,05 % TTMzero RT

Siegfried AG / Key word(s): Personnel
Changes in Siegfried's senior management team

06.12.2024 / 06:30 CET/CEST


Media Release
Zofingen, December 6, 2024

Stefan Randl will join as Chief Scientific Officer and member of the Executive Committee as of January 1, 2025. He will succeed Jürgen Roos who has decided to leave the company to take a well-deserved sabbatical. Stefan joins from Evonik, where he has held various leadership positions in several regions over the past 16 years, most recently as Vice President Innovation Management Health Care, based in Frankfurt, Germany, and as Vice President Drug Substance, based in Indiana, US. He also headed Sales & Services for Health Care in Asia, based in Tokyo. He holds a PhD in Organic Chemistry from the Technische Universität Berlin. 

Olesia Silanteva has been appointed as Chief Human Resources Officer and member of the Executive Committee effective April 1, 2025. She will replace Irene Wosgien who is stepping down from her responsibilities as Chief Human Resources Officer. Olesia will join from Sandoz where she has been People & Organization (P&O) Head for the Technical Operations since 2020, overseeing almost 11000 employees across 18 sites. Olesia is an accomplished P&O professional with more than 20 years of experience driving large-scale operations and transformations across industries. Prior to her current role, she held a number of senior P&O roles at Novartis in Russia and Switzerland. Olesia holds a Corporate MBA from the Stockholm School of Economics and a Diploma in Teaching from Pskov Pedagogical Institute. 

Luca Dalla Torre will join the Executive Committee as Chief Legal and Sustainability Officer as of January 1, 2025. Luca joined Siegfried in 2012 and has since assumed growing responsibilities in the field of legal, intellectual property, compliance, and insurance. In addition, he has been holding the responsibility of Chairman of the Sustainability Board since 2021. Prior to joining Siegfried, he held senior positions with corporate law firms in Zurich and New York, with a focus on mergers and acquisitions and corporate law. Luca holds a PhD in law and a Bachelor of economics from the University of Berne. He also holds an LL.M. in corporate law from New York University and has recently completed a Professional Certificate in sustainability from MIT. 

Marcel Imwinkelried, Chief Executive Officer Siegfried: "I am very delighted with the additions to the Executive Committee. Stefan Randl has a deep understanding of our Drug Products and Drug Substances business and brings profound technical expertise to the team. Olesia Silanteva has an extensive and impressive track record in supporting and advancing people and organizations. Luca Dalla Torre has been instrumental in our very positive development over the last 12 years and will further sharpen our focus on sustainability. All three will strengthen our executive team and bring their ideas and energy to help us successfully continue our growth trajectory in line with our EVOLVE+ strategy. I would like to thank Jürgen and Irene for their valuable contributions to Siegfried's journey of growth over the past years.” 

  • Stefan Randl will become Chief Scientific Officer  
  • Olesia Silanteva will join as Chief Human Resources Officer 
  • Luca Dalla Torre, currently General Counsel, has been appointed to the Executive Committee as Chief Legal and Sustainability Officer 

Contact

Financial Analysts:

Media:
Dr. Reto Suter Peter Stierli
Chief Financial Officer Head Corporate Communications
reto.suter@siegfried.ch peter.stierli@siegfried.ch
Tel. +41 62 746 11 35 Tel. +41 62 746 15 51
   
   
Siegfried Holding AG  
Untere Bruehlstrasse 4
CH-4800 Zofingen

About Siegfried

The Siegfried Group is a global life sciences company with sites in Switzerland, Germany, Spain, France, Malta, the USA and China. In 2023, the company achieved sales of CHF 1.272 billion and employed on 31.12.2023 more than 3700 people at twelve sites on three continents. Siegfried Holding AG is publicly listed on the SIX Swiss Exchange (SIX: SFZN).

Siegfried is active in manufacturing pharmaceutical APIs (and their intermediates) as well as drug products (tablets, capsules, sterile vials, ampoules, cartridges and ointments) for the pharmaceutical industry and provides development services. 



Cautionary Statements Regarding Forward-Looking Statements


This media release includes statements concerning the future. They are based on assumptions and expectations that may prove to be wrong. They should be considered with due caution as, by definition, they contain known and unknown risks, insecurities and other factors which could result in a difference in the actual results, financial situation, developments or the success of Siegfried Holding AG or Siegfried Group from the explicit or implicit assumptions made in these statements.

expect more
 

Siegfried AG
Untere Brühlstrasse 4
4800 Zofingen, Switzerland

+41 62 746 11 11

info@siegfried.ch
www.siegfried.ch

 



End of Media Release


Language: English
Company: Siegfried AG
Untere Brühlstrasse 4
4800 Zofingen
Switzerland
Phone: +41 62 746 11 11
E-mail: info@siegfried.ch
Internet: https://www.siegfried.ch
ISIN: CH0014284498
Listed: SIX Swiss Exchange
EQS News ID: 2044219

 
End of News EQS News Service

2044219  06.12.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2044219&application_name=news&site_id=boersennews_de~~~d41e2cc8-bdcb-47ba-bb51-c77a04513666
Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer